FDA
approval
· 2017-11-21
FDA Approved: ABACAVIR — Original Application (Cipla USA Inc.)
Summary
The FDA approved Cipla USA's generic abacavir under an original ANDA for use in HIV-1 infection as part of combination antiretroviral therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ABACAVIR (ABACAVIR)